SGS SA (SGSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description - A detailed description of the company’s operations and business divisions.
Corporate strategy - Analyst’s summarization of the company’s business strategy.
SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
Company history - Progression of key events associated with the company.
Major products and services - A list of major products, services and brands of the company.
Key competitors - A list of key competitors to the company.
Key employees - A list of the key executives of the company.
Executive biographies - A brief summary of the executives’ employment history.
Key operational heads - A list of personnel heading key departments/functions.
Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
SGS SA (SGS) is a company in the field of testing, inspection, and certification. The company specializes in providing essential services that ensure quality, safety, and compliance across various sectors. SGS offers a range of services, including testing to verify that products and materials meet health, safety, and regulatory requirements, inspection to assess quantity and quality, and certification to confirm that products, services, processes, and systems meet international and local standards. Notable brands associated with SGS include Applied Technical Services, Brightsight, Bluesign, and Nutrasource. SGS’s services are utilized by organizations in industries such as chemical, oil and gas, agriculture and food, construction, energy, life sciences, arts and culture, mining, public sector, logistics, industrial manufacturing, consumer goods and retail, environment and transportation. It operates a network of laboratories and business facilities across North America, Europe, Latin America, Eastern Europe, Middle East & Africa, and Asia Pacific. SGS is headquartered in Geneva, Switzerland.
SGS SA Key Recent Developments
Jun 19, 2026: Carbon Footprint Radar Launched by Sami and SGS
Jun 09, 2026: SGS Issues ESG Report Verification Statement for Tenghui Photovoltaic at SNEC
Jun 04, 2026: SGS Launches ISO 14001:2026 Version Transition Self-Inspection Checklist
Jun 03, 2026: CMIC Holdings Agrees With SGS to Transfer All Shares of CMIC, Inc.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company
NovoCure Ltd - Key Facts
NovoCure Ltd - Key Employees
NovoCure Ltd - Key Employee Biographies
NovoCure Ltd - Major Products and Services
NovoCure Ltd - History
NovoCure Ltd - Company Statement
NovoCure Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 - Company Analysis
Company Overview
NovoCure Ltd - Business Description
Geographical Segment: France
Performance
Geographical Segment: Germany
Performance
Geographical Segment: Greater China
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other international markets
Performance
Geographical Segment: United States
Performance
R&D Overview
NovoCure Ltd - Corporate Strategy
NovoCure Ltd - SWOT Analysis
SWOT Analysis - Overview
NovoCure Ltd - Strengths
NovoCure Ltd - Weaknesses
NovoCure Ltd - Opportunities
NovoCure Ltd - Threats
NovoCure Ltd - Key Competitors
Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
NovoCure Ltd, Medical Equipment, Deals By Year, 2020 to YTD 2026
NovoCure Ltd, Medical Equipment, Deals By Type, 2020 to YTD 2026
NovoCure Ltd, Recent Deals Summary
Section 5 - Company’s Recent Developments
Jun 18, 2026: Novocure’s Optune Gio fails to show benefit at earlier stage
Jun 16, 2026: End Brain Cancer Initiative Releases Free Brain Cancer Education Videos on GBM/rGBM Treatment Options
May 21, 2026: End Brain Cancer Initiative Announces 2026 National HOPE Award Recipient
Apr 01, 2026: Novocure to Report Q1 2026 Financial Results
Mar 26, 2026: Novocure Reports Positive Topline Results From Phase 2 PANOVA-4 Trial of Tumor Treating Fields Therapy in Metastatic Pancreatic Cancer
Mar 02, 2026: Novocure Announces Optune Lua Reimbursement Approval in Japan for Non-Small Cell Lung Cancer
Feb 27, 2026: Novocure Management To Attend 2026 Leerink Global Healthcare Conference
Feb 26, 2026: Novocure Reports Fourth-Quarter and Full-Year 2025 Financial Results and Company Update
Feb 12, 2026: FDA Approves First-of-Its-Kind Electric-Field Device for Advanced Pancreatic Cancer
Jan 12, 2026: Novocure Reports Preliminary Full-Year and Q4 2025 Results and Company Update
Section 6 - Appendix
Methodology
Ratio Definitions
About the Analyst
Contact the Publisher
Disclaimer
List of Tables
NovoCure Ltd, Key Facts
NovoCure Ltd, Key Employees
NovoCure Ltd, Key Employee Biographies
NovoCure Ltd, Major Products and Services
NovoCure Ltd, History
NovoCure Ltd, Other Locations
NovoCure Ltd, Subsidiaries
NovoCure Ltd, Key Competitors
NovoCure Ltd, Ratios based on current share price
NovoCure Ltd, Annual Ratios
NovoCure Ltd, Interim Ratios
NovoCure Ltd, Medical Equipment, Deals By Year, 2020 to YTD 2026
NovoCure Ltd, Medical Equipment, Deals By Type, 2020 to YTD 2026
NovoCure Ltd, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
NovoCure Ltd, Performance Chart (2021 - 2025)
NovoCure Ltd, Ratio Charts
NovoCure Ltd, Medical Equipment, Deals By Year, 2020 to YTD 2026
NovoCure Ltd, Medical Equipment, Deals by Type, 2020 to YTD 2026
This product is a company SWOT Analysis. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a company SWOT Analysis. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a company SWOT Analysis. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net